Specialty Pharmacy

Link found between race and breast cancer life expectancy.

Dogs show promise in sniffing out melanoma, bladder, lung, breast, and ovarian cancers.

Access to high cost curative antiviral HCV drugs remains a challenge for patients.

Psoriasis treatment may improve more than just skin issues.

Research may lead to improve rheumatoid arthritis treatment.

Genetically reduced vitamin D levels could increase susceptibility to MS.

Drug shows promise treating chronic and potentially life-threatening skin disease.

Health care professionals advised to discontinue drug regimen when appropriate.

Nanotechnology may lead to breakthroughs in the treatment of several diseases.

Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.

The 340B Program "mega-guidance" just released by the Health Resources and Services Administration (HRSA) clarifies how patients can receive deeply discounted drugs.

A significant increase in breast cancer development was found among a specific subset of women.

Recent developments in cancer treatment and research.

Beta-blockers found reduce to stress from hormones that fuel disease progression.

Study may help improve early cancer detection.

Researchers evaluate the benefits of subcutaneous methotrexate compared with the oral version.

Higher levels of physical activities leads to lower MS relapse rates.

Amgen is seeking FDA approval for etelcalcetide, the first calcimimetic agent administered intravenously after dialysis to treat secondary hyperparathyroidism in patients with chronic kidney disease.

An independent pharmacy will pay a $46,000 settlement over an alleged lack of break times for its employees.

Study estimates United States is wasting $45 million every month that biosimilar Zarxio is not on the market.

Top stories of the week on Specialty Pharmacy Times.

Findings may better predict organ rejection before transplantation.

Device may eventually detect cancer and diabetes.

Researchers target the spread of diseases such as HIV, SARS, and Ebola.

Pharmacists must prepare for full enforcement of the Drug Supply Chain Security Act (DSCSA) in order to avoid significant penalties associated with noncompliance.

Highly effective cholesterol-lowering drug to challenge Regeneron & Sanofi's Praluent.

Blocking oxygen sensor may improve colorectal cancer treatment.

Treatment has complementary actions that help control blood glucose.